Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Assets (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Return on Assets data on record, last reported at 0.43% in Q4 2025.

  • For Q4 2025, Return on Assets rose 127.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.43%, up 127.0%, while the annual FY2025 figure was 0.38%, 71.0% up from the prior year.
  • Return on Assets reached 0.43% in Q4 2025 per VRCA's latest filing, up from 0.61% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.34% in Q2 2023 and bottomed at 2.0% in Q3 2024.
  • Average Return on Assets over 5 years is 0.85%, with a median of 0.61% recorded in 2025.
  • Peak YoY movement for Return on Assets: plummeted -140bps in 2024, then skyrocketed 140bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.42% in 2021, then fell by -18bps to 0.49% in 2022, then crashed by -53bps to 0.75% in 2023, then crashed by -127bps to 1.7% in 2024, then soared by 75bps to 0.43% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.43% in Q4 2025, 0.61% in Q3 2025, and 1.15% in Q2 2025.